Join
Live feed
·
PRReleasevia Quantisnow
Amarin Corporation plc logo

New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia

ByQuantisnow·Wall Street's wire, on your screen.
AMRN· Amarin Corporation plc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMRN (Amarin Corporation plc) and more on Quantisnow.